InMode (NASDAQ:INMD – Get Free Report) is scheduled to announce its earnings results before the market opens on Wednesday, October 30th. Analysts expect the company to announce earnings of $0.44 per share for the quarter. Investors that are interested in registering for the company’s conference call can do so using this link.
InMode (NASDAQ:INMD – Get Free Report) last announced its quarterly earnings results on Thursday, August 1st. The healthcare company reported $0.34 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.38 by ($0.04). InMode had a net margin of 35.81% and a return on equity of 21.00%. The firm had revenue of $102.60 million for the quarter, compared to analyst estimates of $104.81 million. During the same period last year, the firm posted $0.65 EPS. The business’s revenue was down 24.6% compared to the same quarter last year. On average, analysts expect InMode to post $2 EPS for the current fiscal year and $2 EPS for the next fiscal year.
InMode Stock Performance
Shares of INMD opened at $18.35 on Wednesday. InMode has a 1 year low of $14.87 and a 1 year high of $26.80. The company has a market cap of $1.54 billion, a price-to-earnings ratio of 8.70 and a beta of 2.17. The firm has a fifty day moving average of $16.38 and a 200-day moving average of $17.38.
Analyst Ratings Changes
View Our Latest Research Report on INMD
About InMode
InMode Ltd. designs, develops, manufactures, and markets minimally invasive aesthetic medical products based on its proprietary radiofrequency assisted lipolysis and deep subdermal fractional radiofrequency technologies in the United States and internationally. The company offers minimally invasive aesthetic medical products for various procedures, such as liposuction with simultaneous skin tightening, body and face contouring, and ablative skin rejuvenation treatments, as well as for use in women's health conditions and procedures.
Recommended Stories
- Five stocks we like better than InMode
- Stock Splits, Do They Really Impact Investors?
- How Verizon Could Offer Stress-Free Double-Digit Returns in 2025
- 3 Healthcare Dividend Stocks to Buy
- Can Roche Challenge Lilly and Novo in the Weight Loss Market?
- CD Calculator: Certificate of Deposit Calculator
- Roblox Stock: Key Metrics Surge, Is This the Perfect Entry?
Receive News & Ratings for InMode Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for InMode and related companies with MarketBeat.com's FREE daily email newsletter.